Role of phospholipase A2 on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases

被引:73
作者
Boulanger, Y [1 ]
Labelle, M [1 ]
Khiat, A [1 ]
机构
[1] Univ Montreal, Ctr Hosp, Hop St Luc, Dept Radiol, Montreal, PQ H2X 3J4, Canada
关键词
choline; phospholipase A(2); magnetic resonance spectroscopy; brain disease; phospholipids; metabolism;
D O I
10.1016/S0165-0173(00)00037-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Phospholipase Az catalyzes the hydrolysis of membrane glycerophospholipids leading to the production of metabolites observable by both H-1 and P-31 magnetic resonance spectroscopy. The signal of choline-containing compounds (Cho) observed by H-1 magnetic resonance spectroscopy is constituted of metabolites of phosphatidylcholine, especially phosphocholine (PCho) and glycerophosphocholine (GPCho). The phosphomonoester (PME) and phosphodiester (PDE) signals observed by P-31 magnetic resonance spectroscopy are, respectively, precursors and catabolites of phospholipids. A large number of brain diseases have been reported to cause variations in the intensity of the Cho, PME and PDE signals. Changes in the activity of phospholipase A(2) have been measured in many brain diseases. In this review, the relationships between the results of H-1 and P-31 magnetic resonance spectroscopy and the phospholipase A(2) assays are analyzed. In many brain diseases, the variation in the Cho signal intensity can be correlated with a stimulation or inhibition of the phospholipase A(2) activity. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:380 / 389
页数:10
相关论文
共 116 条
[91]   BRAIN PHOSPHOLIPASE-A2 IS ACTIVATED AFTER EXPERIMENTAL CLOSED HEAD-INJURY IN THE RAT [J].
SHOHAMI, E ;
SHAPIRA, Y ;
YADID, G ;
REISFELD, N ;
YEDGAR, S .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (05) :1541-1546
[92]   Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain [J].
Simmons, A ;
Smail, M ;
Moore, E ;
Williams, SCR .
MAGNETIC RESONANCE IMAGING, 1998, 16 (03) :319-330
[93]   Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV [J].
Simone, IL ;
Federico, F ;
Tortorella, C ;
Andreula, CF ;
Zimatore, GB ;
Giannini, P ;
Angarano, G ;
Lucivero, V ;
Picciola, P ;
Carrara, D ;
Bellacosa, A ;
Livrea, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (04) :516-523
[94]   Cytosolic phospholipase A(2) (cPLA(2)) immunoreactivity is elevated in Alzheimer's disease brain [J].
Stephenson, DT ;
Lemere, CA ;
Selkoe, DJ ;
Clemens, JA .
NEUROBIOLOGY OF DISEASE, 1996, 3 (01) :51-63
[95]   CHOLINE INGESTION INCREASES THE RESONANCE OF CHOLINE-CONTAINING COMPOUNDS IN HUMAN BRAIN - AN IN-VIVO PROTON MAGNETIC-RESONANCE STUDY [J].
STOLL, AL ;
RENSHAW, PF ;
DEMICHELI, E ;
WURTMAN, R ;
PILLAY, SS ;
COHEN, BM .
BIOLOGICAL PSYCHIATRY, 1995, 37 (03) :170-174
[96]   Macrophage responses to Toxoplasma antigens in vitro:: A possible role in inflammatory lesions in toxoplasmosis [J].
Tackey, RN ;
Kassim, OO .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (02) :272-279
[97]   Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain [J].
Tan, J ;
Bluml, S ;
Hoang, T ;
Dubowitz, D ;
Mevenkamp, G ;
Ross, B .
MAGNETIC RESONANCE IN MEDICINE, 1998, 39 (06) :1005-1010
[98]   A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease [J].
Taylor-Robinson, SD ;
Turjanski, N ;
Bhattacharya, S ;
Seery, JP ;
Sargentoni, J ;
Brooks, DJ ;
Bryant, DJ ;
Cox, IJ .
METABOLIC BRAIN DISEASE, 1999, 14 (01) :45-55
[99]   Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy [J].
Taylor-Robinson, SD ;
Buckley, C ;
Changani, KK ;
Hodgson, HJF ;
Bell, JD .
LIVER, 1999, 19 (05) :389-398
[100]   REGIONAL VARIATIONS IN CEREBRAL PROTON SPECTROSCOPY IN PATIENTS WITH CHRONIC HEPATIC-ENCEPHALOPATHY [J].
TAYLORROBINSON, SD ;
SARGENTONI, J ;
MARCUS, CD ;
MORGAN, MY ;
BRYANT, DJ .
METABOLIC BRAIN DISEASE, 1994, 9 (04) :347-359